| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/18/2005 | CN1617882A Method of isolation and purification of trypsin from pronase protease and use thereof |
| 05/18/2005 | CN1617732A Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 05/18/2005 | CN1616662A Pseudo monads pseudoalcaligenes gene promoter |
| 05/18/2005 | CN1616661A Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
| 05/18/2005 | CN1616652A Gene engineering bacteria of high efficiency expression of human alpha 1-thymulin and its construction method and use |
| 05/18/2005 | CN1616651A Vancomycine producing fungus and its use |
| 05/18/2005 | CN1616484A Novel cyclopeptide anti-tumor, anti-virus antibiotic active compound |
| 05/18/2005 | CN1616084A Botulinum toxin pharmaceutical compositions |
| 05/18/2005 | CN1202261C Methods for making recombinant cells |
| 05/18/2005 | CN1202252C Recombination proteins of Pakistani strain of hepatitis E and their use in diagnostic method and vaccines |
| 05/18/2005 | CN1202132C IgG Fab-BPI fusion protein and DNA sequence thereof |
| 05/18/2005 | CN1202129C GDNF mutant and its medical application |
| 05/18/2005 | CN1202128C Immunogenicity of modified protein |
| 05/18/2005 | CN1202127C Immunostimulant bacterial membrane tractions in cancer treatment |
| 05/18/2005 | CN1201818C Vaccine |
| 05/17/2005 | US6894157 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 05/17/2005 | US6894149 Monoclonal/polyclonal human leukocyte antigen (HLA) antibodies for use in the treatment of leukemias, lymphomas, or solid tumors of ovaries; antitumor agents; apoptosis |
| 05/17/2005 | US6894147 Intermediate conductance calcium-activated potassium channels (IK1) |
| 05/17/2005 | US6893869 For treatment of cancer/tumors/fungal/viral infections; tumor associated antigens; genetic engineering |
| 05/17/2005 | US6893858 Human kcnq5 potassium channel, methods and compositions thereof |
| 05/17/2005 | US6893844 DNA encoding a new human hepatoma derived growth factor and producing method thereof |
| 05/17/2005 | US6893843 Nucleic acids |
| 05/17/2005 | US6893840 Cytomegalovirus Intron A fragments |
| 05/17/2005 | US6893839 Isolated cyclohexadepsipeptide synthetases and isolated nucleic acid sequences encoding the cyclohexadepsipeptide synthetases |
| 05/17/2005 | US6893838 DADD, death activator death domain protein |
| 05/17/2005 | US6893827 Receptor function assay for G-protein coupled receptors and orphan receptors by reporter enzyme mutant complementation |
| 05/17/2005 | US6893638 Methods for treating b cell lymphoma using CD80-specific antibodies |
| 05/17/2005 | US6893636 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 05/17/2005 | CA2375673C Dna sequences derived from the genome of the papillomavirus hpv39, their application to in vitro diagnostic and to the production of immunogen compositions |
| 05/17/2005 | CA2235845C Prostaglandin d synthase-specific monoclonal antibody |
| 05/17/2005 | CA2234409C Transferrin receptor protein of moraxella |
| 05/17/2005 | CA2202390C Keratinocyte growth factor analogs |
| 05/17/2005 | CA2182393C Dna mutagenesis by random fragmentation and reassembly |
| 05/17/2005 | CA2115151C Tau/neurofilament protein kinases pk40 and pk36 |
| 05/12/2005 | WO2005043119A2 Methods and compositions for the identification of anti-poxvirus agents |
| 05/12/2005 | WO2005042758A1 Method for flocculation of a fermentation broth comprising a fungus |
| 05/12/2005 | WO2005042753A1 Production of human glycosylated proteins in transgenic insects |
| 05/12/2005 | WO2005042720A2 Kahalalide-producing bacteria |
| 05/12/2005 | WO2005042569A1 Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction |
| 05/12/2005 | WO2005042469A1 Aromatic amino acid labeled with stable isotope, method for incorporating the same into target protein and method for analyzing protein structure using nmr |
| 05/12/2005 | WO2005041880A2 RhPV AS A MODEL FOR HPV-INDUCED CANCERS |
| 05/12/2005 | WO2005041680A2 A novel colostral fractionation process |
| 05/12/2005 | WO2005026192A3 Hpv cd8+ t-cell epitopes |
| 05/12/2005 | WO2005021777A3 Uses of spatial configuration to modulate protein function |
| 05/12/2005 | WO2004111240A3 Sequence for the bacillomycin d synthesis in bacillus amyloliquefaciens fzb42 |
| 05/12/2005 | WO2004035605A3 Glycoprotein synthesis |
| 05/12/2005 | WO2003085124A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 05/12/2005 | WO2003022126A3 Compositions and methods for the therapy and diagnosis of colon cancer |
| 05/12/2005 | WO2001079525A3 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 05/12/2005 | US20050101773 Genes required for viability and/or reproduction in c. elegans and their use in the development of anti-nematode agents |
| 05/12/2005 | US20050101556 Genetic engineering; Alzheimer's disease; anticancer agents |
| 05/12/2005 | US20050101529 Protein modification and maintenance molecules |
| 05/12/2005 | US20050100987 Using ribonucleoside diphosphate reductase intein as tool to generate preferential amino terminal protein fusion; directed protein evolution |
| 05/12/2005 | US20050100952 Transgenic mammalian cells for use as bioreactors in expression of heterologous gene sequences |
| 05/12/2005 | US20050100942 Nucleotide sequences coding RNA for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 05/12/2005 | US20050100918 Mammalian receptor proteins; related reagents and methods |
| 05/12/2005 | US20050100917 Mammalian receptor proteins; related reagents and methods |
| 05/12/2005 | US20050100914 Using methylation profile of testes-specific protease (TSP50) genes as disgnoatic tool in detection of breast cancer |
| 05/12/2005 | US20050100882 Viral polypeptide fusion comprising guanylyltransferase, methyltransferase and polymerase activities for use as tool in identifying modulator of viral propagation; viricides |
| 05/12/2005 | US20050100554 Chimeric polypeptides, vectors and cells; test for precancerous cells; human papilloma virus |
| 05/12/2005 | US20050100545 Mutated antibody does not possess O-linked glycosylation, nucleic acids encoding prevents N-linked glycosylation; humanized and conjugated with radionucleotide to image target cells |
| 05/12/2005 | US20050100541 Ligands, including antibodies, showing reactivity against endocrine cells |
| 05/12/2005 | US20050100540 Platelet-activating factor acetylhydrolase |
| 05/12/2005 | CA2544300A1 Dose-dependent promoter originating in humans |
| 05/12/2005 | CA2543127A1 Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods |
| 05/12/2005 | CA2542951A1 Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction |
| 05/12/2005 | CA2536238A1 Humanization of antibodies |
| 05/11/2005 | EP1529844A2 Complex formation for the stabilisation and purification of proteins of interest |
| 05/11/2005 | EP1529837A2 Microorganisms producing dipeptides and process for producing dipeptides using the microorganisms |
| 05/11/2005 | EP1529784A1 Polymeric anhydride of magnesium and proteic ammonium phospholinoleate-palmitoleate. |
| 05/11/2005 | EP1529114A1 Process for preparing peptides with anti-hypertensive properties |
| 05/11/2005 | EP1529113A1 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 05/11/2005 | EP1529109A2 Production of multimeric fusion proteins using a c4bp scaffold |
| 05/11/2005 | EP1529055A2 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof |
| 05/11/2005 | EP1248802B9 Soluble ctla4 mutant molecules and uses thereof |
| 05/11/2005 | EP1088069B1 Angiostatin-binding protein |
| 05/11/2005 | EP0944725B1 Phosphodiesterase 8 |
| 05/11/2005 | EP0839196B1 Human ctla-8 and uses of ctla-8-related proteins |
| 05/11/2005 | EP0730606B1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR |
| 05/11/2005 | EP0625200B1 Biosynthetic binding protein for cancer marker |
| 05/11/2005 | CN1615359A Process for producing l-amino acid using escherichia |
| 05/11/2005 | CN1615143A Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors |
| 05/11/2005 | CN1614028A Dried bacterial powder process containing gamma-linolenic acid |
| 05/11/2005 | CN1614025A Method and use of producing soluble recombinant protein in colibacillus |
| 05/11/2005 | CN1614019A Secretory expression for human insulin gene in methyl alcohol yeast |
| 05/11/2005 | CN1614016A Production of human interleukin 288 and recombined IL-288 engineering bacteria |
| 05/11/2005 | CN1614003A Culture of Chansi mould strains and extraction and use of anagentic compound therefrom |
| 05/11/2005 | CN1613873A Anti-cancer surface antigen of p185 monoantigen embedded antibody and its preparation |
| 05/11/2005 | CN1613870A Tetramer combined with SARS antigen peptide and its preparation and use |
| 05/11/2005 | CN1201150C Composite, chemical luminescent system and its applications |
| 05/11/2005 | CN1201011C Heterologous expression of neisserial proteins |
| 05/11/2005 | CN1201010C Mass production method of antimicrobial peptide and DNA construct and expression system thereof |
| 05/11/2005 | CN1201006C High-affinity interleukin-4 muteins |
| 05/11/2005 | CN1201005C Antigen binding fragments that specifically detect cancer cells, nucleotindes encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/11/2005 | CN1201004C HER-2/neu fusion proteins |
| 05/11/2005 | CN1201003C Adipocyte-specific protein homologs |
| 05/11/2005 | CN1200950C Immuno-conjugated compound as protein or nucleic acid trasnferring carrier |
| 05/10/2005 | US6892140 Immunogenic cancer peptides and uses thereof |
| 05/10/2005 | US6891028 Nucleic acids encoding transferrin receptor-like proteins |
| 05/10/2005 | US6891027 Composition for use in the modulation of immunological response |